Cargando…
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer
BACKGROUND: At diagnosis, tumor-infiltrating lymphocytes (TILs) are prognostic in epithelial ovarian cancer (EOC). We recently demonstrated that neoadjuvant chemotherapy (NACT) significantly increased stromal TILs. Here, we investigated the impact of NACT on immune subpopulations with a particular f...
Autores principales: | Leary, Alexandra, Genestie, Catherine, Blanc-Durand, Félix, Gouy, Sébastien, Dunant, Ariane, Maulard, Amandine, Drusch, Françoise, Cheaib, Bianca, Michels, Judith, Bentivegna, Enrica, LeFormal, Audrey, Mesnage, Soizick, Morice, Philippe, Pautier, Patricia, Khairallah, Aya S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889679/ https://www.ncbi.nlm.nih.gov/pubmed/32852603 http://dx.doi.org/10.1007/s00262-020-02670-0 |
Ejemplares similares
-
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
por: Genestie, Catherine, et al.
Publicado: (2019) -
Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2020) -
Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?
por: Gouy, Sebastien, et al.
Publicado: (2017) -
Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types
por: Gouy, Sebastien, et al.
Publicado: (2017) -
Cervical Cancer and Fertility-Sparing Treatment
por: Zaccarini, François, et al.
Publicado: (2021)